Clinical Trial Update: Urinary Biomarker-Based Diagnostic and Monitoring System for Chronic Kidney Disease and Real-World Effectiveness of SGLT2 Inhibitors

View source ↗

Summary

A clinical trial update describes a urinary biomarker-based diagnostic and monitoring system for chronic kidney disease and assesses real-world effectiveness of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Instituto de Investigación Biomédica de Salamanca | Conditions: Chronic Kidney Disease | Status: NOT_YET_RECRUITING